TEAM
Recognized Trailblazers and Innovators
Our Team
Twenty years ago, the core members of our team pioneered the leading BPH surgical technology and established bipolar plasma treatment as a surgical standard of care. Today, we have assembled a distinguished team of advisors who are internationally-respected thought leaders on BPH care. Our collective experience brings meaningful improvement for all BPH surgery stakeholders by making better procedures easy and more accessible than ever.
Team
Recognized Trailblazers and Innovators
Our story aligns closely with the evolution of BPH surgery. More than a decade ago, our core team helped bring a leading BPH surgical business to market—and established bipolar TURP treatments as a standard of care. Now, Tiumed is advancing treatment standards once again to closer align with the future of BPH care.
Scott Latterell
Founder and CEO
Scott brings 30 years of experience in the medical device market, including over 20 years focused specifically on urology. As the Director of Urology for Gyrus Medical, he orchestrated the launch and advancement of bipolar plasma technology as the new industry standard for BPH surgical care and established Gyrus as a market leader. While with KARL STORZ Endoscopy America, Scott led the urology business to become its largest, most profitable specialty with $110M in annual sales.
Craig Swandal
Senior Strategic Advisor and Board Member
Craig’s extensive executive management experience includes more than 20 years in the medical device industry, with a focus on global manufacturing strategy and execution. As a senior executive for Gyrus Medical, Craig managed the development of Gyrus’ bipolar plasma system and was integral to the successful acquisition and integration of ACMI, including their extensive portfolio of urology-specific products. He was also a key player in the successful sale of Gyrus ACMI to Olympus for $2.2B.
Rich Nazarian
Board Member
Rich has been a leader in the med-tech industry for over 35 years. As a founder and CEO of Minnetronix Medical, Rich guided its revenue growth over 25 years to $100M+ and assembled a world-class workforce of over 300 employees. Working with medical device companies, ranging from start-ups to the worlds largest, Minnetronix has completed hundreds of development programs and introduced dozens of FDA class II and III products to the market. Prior to Minnetronix, Rich enjoyed a successful career in 3M’s Cardiovascular Systems Division.
Dr. Ricardo Gonzalez
Medical Advisory Board Member
Dr. Gonzalez is an academic faculty member at Houston Methodist Hospital with faculty affiliations at Texas A&M and Baylor College of Medicine. He is an internationally recognized expert in surgical therapies for BPH, including GreenLight laser vaporization of the prostate, enucleation, Rezum, Urolift, Aquablation and others. Previously, he served as the Medical Director for the Centers for Voiding Dysfunction and Clinical Research at Houston Metro Urology.
Dr. Gregg Eure
Medical Advisory Board Member
Dr. Eure is Chairman of the Urology of Virginia Research Department and a member of the International Medical Educational Board. He is an internationally recognized and respected leader in the research of new BPH treatments and he is widely regarded as an expert in the use of GreenLight laser vaporization of the prostate. He is active in BPH clinical research and has been an investigator in numerous clinical trials advancing minimally invasive treatments.
Astrid Berthe
Senior Strategic Advisor, Quality and Regulatory
Astrid brings more than 30 years of management, leadership and technical experience focusing on quality systems, regulatory compliance, engineering, manufacturing operations and regulatory affairs. Astrid currently serves as the Vice President of Regulatory Affairs and Quality Assurance at 2C Tech. Prior to that, she held similar roles with both Oraya Therapeutics and ATS Medical. She has also held leadership positions at Baxter Healthcare, Medtronic and Isotis Orthobiologics.